Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion.
作者信息
Mizrahi Meir, Adar Tomer, Orenbuch-Harroch Efrat, Elitzur Yair
机构信息
Internal Medicine A, Department of Medicine, Hebrew University-Hadassah Medical Center, Jerusalem IL 91120, Israel.
出版信息
Case Rep Med. 2009;2009:861370. doi: 10.1155/2009/861370. Epub 2010 Feb 22.
Abstract
Intravenous immunoglobulins (IVIgs) are used for several indications, including autoimmune conditions. IVIg treatment is associated with several possible adverse reactions including induction of a hypercoagulable state. We report a 76-year-old woman treated with IVIg for myasthenia gravis, which developed chest pain and weakness following IVIg infusion. The symptoms were associated with ST segment depression in V4-6 and elevated troponin levels. The patient was diagnosed with non-ST elevation myocardial infarction (NSTEMI). The patient had no significant risk factor besides age and a cardiac perfusion scan was interpreted as normal (the patient refused to undergo cardiac catheterization). This case is compatible with IVIg-induced hypercoagulability resulting in NSTEMI. Cardiac evaluation should therefore be considered prior to initiation of IVIg treatment especially in patients with multiple cardiovascular risks.
摘要
相似文献
1
Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion.
Case Rep Med. 2009;2009:861370. doi: 10.1155/2009/861370. Epub 2010 Feb 22.
2
Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report.
BMC Neurol. 2020 Aug 28;20(1):319. doi: 10.1186/s12883-020-01901-2.
3
Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
Ann N Y Acad Sci. 2007 Sep;1110:315-8. doi: 10.1196/annals.1423.033.
4
Myocardial infarction associated with intravenous immune globulin.
Ann Pharmacother. 2005 Dec;39(12):2114-8. doi: 10.1345/aph.1G104. Epub 2005 Nov 15.
5
Frequency of Multivessel Severe Coronary Artery Disease in Patients With Non-ST Segment Elevation Myocardial Infarction Having Markedly Raised Cardiac Troponin T.
Cureus. 2020 Aug 5;12(8):e9571. doi: 10.7759/cureus.9571.
6
Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration.
Ann Allergy Asthma Immunol. 2007 Dec;99(6):567-70. doi: 10.1016/S1081-1206(10)60388-2.
7
Contemporary NSTEMI management: the role of the hospitalist.
Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20.
8
Intravenous immunoglobulin in the treatment of neurologic disorders.
Acta Neurol Scand. 2016 Feb;133(2):84-96. doi: 10.1111/ane.12444. Epub 2015 May 21.
9
Intravenous immunoglobulin for myasthenia gravis.
Cochrane Database Syst Rev. 2008 Jan 23(1):CD002277. doi: 10.1002/14651858.CD002277.pub3.
10
Low-dose intravenous immunoglobulin therapy in myasthenia gravis: a case report.
Zhonghua Yi Xue Za Zhi (Taipei). 1996 Mar;57(3):232-5.
引用本文的文献
1
Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma.
Front Pharmacol. 2025 Feb 26;16:1543612. doi: 10.3389/fphar.2025.1543612. eCollection 2025.
2
A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome.
Front Med (Lausanne). 2024 Apr 11;11:1348941. doi: 10.3389/fmed.2024.1348941. eCollection 2024.
3
Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest.
J Investig Med High Impact Case Rep. 2018 Jan 29;6:2324709618755414. doi: 10.1177/2324709618755414. eCollection 2018 Jan-Dec.
4
Pulmonary edema in myasthenic crisis.
Case Rep Crit Care. 2013;2013:863620. doi: 10.1155/2013/863620. Epub 2013 Dec 26.
5
Non-coronary myocardial infarction in myasthenia gravis: Case report and review of the literature.
World J Cardiol. 2013 Jul 26;5(7):265-9. doi: 10.4330/wjc.v5.i7.265.
6
Mesalamine-induced myocarditis and coronary vasculitis in a pediatric ulcerative colitis patient: a case report.
Case Rep Pediatr. 2011;2011:524364. doi: 10.1155/2011/524364. Epub 2011 Dec 21.
本文引用的文献
1
Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
Pediatr Neurol. 2008 Aug;39(2):123-5. doi: 10.1016/j.pediatrneurol.2008.04.005.
2
Role of natural antibodies in immune homeostasis: IVIg perspective.
Autoimmun Rev. 2008 Jun;7(6):440-4. doi: 10.1016/j.autrev.2008.04.011. Epub 2008 Apr 28.
3
Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
Ann N Y Acad Sci. 2007 Sep;1110:315-8. doi: 10.1196/annals.1423.033.
4
Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Ann Pharmacother. 2007 Oct;41(10):1604-10. doi: 10.1345/aph.1K198. Epub 2007 Sep 4.
5
Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
Nat Clin Pract Rheumatol. 2007 May;3(5):262-72. doi: 10.1038/ncprheum0481.
6
Safety of intravenous immunoglobulin (IVIG) therapy.
Autoimmun Rev. 2007 Mar;6(4):257-9. doi: 10.1016/j.autrev.2006.08.011. Epub 2006 Aug 28.
7
Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
Nat Clin Pract Neurol. 2007 Jan;3(1):36-44. doi: 10.1038/ncpneuro0376.
8
Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion.
Eur J Pediatr. 2007 Sep;166(9):915-9. doi: 10.1007/s00431-006-0337-3. Epub 2006 Nov 21.
9
Intravenous immunoglobulin and recurrent pregnancy loss.
Clin Rev Allergy Immunol. 2005 Dec;29(3):327-32. doi: 10.1385/CRIAI:29:3:327.
10
Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome.
J Neuroimaging. 2005 Apr;15(2):188-92. doi: 10.1177/1051228404273820.
Zotero 插件